Plus, Fed Chairman Jerome Powell said the central bank is “closely monitoring” the effects of the coronavirus outbreak, and Under Armour shares are sinking after athletic apparel maker said it expects low-single digit sales growth this year.
Read MoreLast month, media buzz related to the ongoing, drawn-out grounding of the Boeing 737 Max prompted me to take a serious look at airline carriers to evaluate their exposure to risk resulting from that issue. That’s because continued delays in the 737 Max have forced airline carriers to cancel flights on a widespread basis and […]
Read MoreTrade Setup Buy Target $119.01 Sell Target $128.97 Cimpress plc provides various mass customization services in North America, Europe, Australia/New Zealand, South America, and the Asia Pacific regions. The company operates through five segments: Vistaprint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. It provides printed and digital marketing products; Internet-based canvas-print wall […]
Read MorePlus, Simon Property Group is acquiring Taubman Centers for $3.6 billion, and Eli Lilly shares are down after a failed trial for its Alzheimer’s drug candidate.
Read MoreBuy Target – $24.00 or better Sell Target – TradersPro Sell Signal Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total […]
Read MoreThe market’s rally to a new set of all-time highs is being taken as a sign that the economy is going to continue to grow throughout the rest of the year, which also means that for a many analysts and investors, the market is expected to maintain its long-term upward trend. The news hasn’t been […]
Read MoreBuy Target – $7.25 or better Sell Target – TradersPro Sell Signal Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates through two segments, Proprietary Products and Distribution. The company offers respiratory products, including Glassia for use in augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 […]
Read MorePlus, the U.S. economy added 225,000 jobs in January, and Myriad Genetics shares are in free fall after it significantly missed on earnings.
Read MoreThe signing of Phase One of a trade deal between the U.S. and China in January gave the market a renewed sense of optimism that long-term trade peace is on the horizon. While this week the market has been rattled by the coronavirus, indications this week suggest that while its impact, particularly in China will […]
Read MoreRecent weakness is presenting a buying opportunity for this chipmaker – and it could see double-digit upside just ahead.
Read MoreToday’s 5 market cap leaders are a better bet than their peers from two decades ago. Here’s why.
Read MoreDemand for this precious metal has ground to a halt and it could be a signal of dark times ahead. Here’s why.
Read MoreBuy Target – $41.00 or better Sell Signal – TradersPro Sell Signal Nova Measuring Instruments Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel. Its product portfolio includes integrated and stand-alone metrology platforms for dimensional, films, and material metrology measurements for process control across various semiconductor manufacturing […]
Read MorePlus, China announced it will halve tariffs on $75 billion worth of U.S. goods, and Yum! Brands warned that it could fall short of its outlook as the coronavirus outbreak weighs on its sales in China.
Read MoreThe market has been rebounding strongly this week, with the S&P 500 pushing yesterday near to its all-time high, while the Nasdaq 100 pushed to a new high two days ago. Fears about the long-term impact of coronavirus appear to be fading as the pace of contagion in China drops, with reports of a breakthrough […]
Read More